Clough Capital Partners L P Amgen Inc Transaction History

Clough Capital Partners L P

$924 Million
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $132,452 - $149,422	-518 Reduced 12.1%	3,762 $1.08 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $2.58 Million - $3.2 Million	-11,800 Reduced 73.38%	4,280 $1.15 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $2.72 Million - $3.21 Million	12,680 Added 372.94%	16,080 $3.57 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $778,702 - $989,434	3,400 New	3,400 $892,000
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $7.09 Million - $8.26 Million	-31,932 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $18 Million - $21.4 Million	-83,185 Reduced 72.26%	31,932 $7.34 Million
Q3 2020 Nov 17, 2020	BUY	$234.65 - $260.95 $13.3 Million - $14.8 Million	56,660 Added 96.93%	115,117 $29.3 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $1.88 Million - $2.31 Million	-9,500 Reduced 13.98%	58,457 $13.8 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $2.63 Million - $3.48 Million	14,410 Added 26.91%	67,957 $13.8 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $1.22 Million - $1.57 Million	6,452 Added 13.7%	53,547 $12.9 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $2.75 Million - $3.3 Million	15,810 Added 50.54%	47,095 $9.11 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $5.54 Million - $6.49 Million	-33,230 Reduced 51.51%	31,285 $5.77 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $1.04 Million - $1.18 Million	5,770 Added 9.82%	64,515 $12.3 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $919,652 - $1.07 Million	-5,155 Reduced 8.07%	58,745 $11.4 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $537,341 - $605,781	-2,900 Reduced 4.34%	63,900 $13.2 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $2.25 Million - $2.53 Million	13,560 Added 25.47%	66,800 $12.3 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $9.02 Million - $10.5 Million	53,240 New	53,240 $9.08 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

News

Stay updated on Clough Capital Partners L P with notifications on news.

Account